July 21, 2020Open Access

Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Very high levels of vWF and factor VIIIc are common in COVID-19 patients, comparable to levels in severely septic non-COVID ICU patients. This could contribute to the hypercoagulable state and increased VTE rate in COVID-19. Further studies are needed to evaluate the use of vWF for stratifying thrombotic risk in COVID-19 and to determine if elevated vWF is contributing to disease pathogenesis.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Ladikou et al. (Tue,) studied this question.

synapsesocial.com/papers/69d71a408a0e2c5879bef131 https://doi.org/https://doi.org/10.7861/clinmed.2020-0346

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Thromboembolic events in patients with severe pandemic influenza A/H1N12015 · 55 citations
2Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China2020 · 51,817 citations
3Trends in Mortality for Medicare Beneficiaries Treated in the Emergency Department From 2009 to 20162019 · 386 citations
4d-dimer is a significant prognostic factor in patients with suspected infection and sepsis2012 · 196 citations
5ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock2007 · 177 citations

Me gusta

Guardar

Ver artículo completo